Sepsis & infection

Ability of diastolic arterial pressure to better characterize the severity of septic shock when adjusted for heart rate and norepinephrine dose

Ann Intensive CarePublished Secondary analysis of the ANDROMEDA-SHOCK randomised trial

Authors' conclusion

In patients receiving NE during early septic shock, VNERi demonstrated the strongest association with outcome compared to DAP, DAP/HR, and MAP/NE dose.

Study context

Population
Patients with septic shock receiving norepinephrine (NE), ANDROMEDA-SHOCK database
Participants
424 patients
Comparison
Association with outcome of VNERi) vs diastolic arterial pressure (DAP), DAP/HR and mean arterial pressure (MAP)/NE dose
Primary endpoint
In-hospital mortality
Methodological detailspost-hoc analysis, multivariate model, Hemodynamic variables and initial NE doses recorded at randomization, within 4 h of septic shock diagnosis
  • Post-hoc analysis
  • Multivariate model
  • Hemodynamic variables and initial NE doses recorded at randomization, within 4 h of septic shock diagnosis

Primary result

As reported in the abstract

In-hospital mortality

43%

Inverted J-shaped relationship between in-hospital mortality and VNERi, nadir point (mortality increased below)

6.7

Further findings

Vasopressor-free days and renal replacement therapy (RRT)-free days up to day 28

Similar findings (VNERi strongest association)

Baseline hemodynamics at inclusion

Median DAP, mmHg [IQR: 45-50]
52
Median NE dose, µg/kg/min [IQR: 01-0.4]
0.2

Original publication

Ability of diastolic arterial pressure to better characterize the severity of septic shock when adjusted for heart rate and norepinephrine dose. Ann Intensive Care. Published 26 March 2025. doi:10.1186/s13613-025-01454-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.